BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) ranks among the top stocks available for under $20. On October 1, BioCryst Pharmaceuticals declared the successful finalization of the previously reported divestiture of its European…

Subscribe Now for Real-time Updates on the Latest Stories!
Ruane, Cunniff LP, an investment adviser managing Sequoia Strategy, recently released its Q4 2025 investor letter, showcasing its impressive performance…
Baron Fund, an investment management company, recently released its Q4 2025 letter for the Baron Small Cap Fund. The market…
Deposit account rates are indeed on the decline, but there is a silver lining for savers looking to secure a…
High-yield savings account rates have been on the decline, but there are still some top accounts that offer impressive interest…
Federal Reserve Bank of Cleveland President Beth Hammack recently expressed her views on the U.S. central bank's interest rate policy…
British oil and gas giant, bp, has recently reported its financial results for the fourth quarter of 2025, showcasing a…
Growth in U.S. Labor Costs Slows in Fourth Quarter The latest data from the Labor Department's Bureau of Labor Statistics…
Bluespring Wealth Partners, the RIA arm of Kestra Holdings, recently made a significant acquisition by acquiring SHP Financial, a Massachusetts-based…
Sign in to your account